CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Risk of malignancy in patients with rheumatoid arthritis after anti-tumor necrosis factor therapy: results from Korean National Health Insurance claims data
Seung Min Jung, Seung-Ki Kwok, Ji Hyeon Ju, Yong-Beom Park, Sung-Hwan Park
Korean J Intern Med. 2019;34(3):669-677.   Published online 2017 November 29    DOI: https://doi.org/10.3904/kjim.2016.374

Excel Download

Risk of malignancy in patients with rheumatoid arthritis after anti-tumor necrosis factor therapy: results from Korean National Health Insurance claims data
The Korean Journal of Internal Medicine. 2019;34(3):669-677   Crossref logo
Link1 Link2 Link3

Outcomes After Switching From One Anti–Tumor Necrosis Factor α Agent to a Second Anti–Tumor Necrosis Factor α Agent in Patients With Rheumatoid Arthritis: Results From a Large UK National Cohort Study
Yearbook of Medicine. 2008;2008:6-7   Crossref logo
Link1 Link2

Outcomes after switching from one anti–tumor necrosis factor α agent to a second anti–tumor necrosis factor α agent in patients with rheumatoid arthritis: Results from a large UK national cohort study
Arthritis & Rheumatism. 2006;56(1):13-20   Crossref logo
Link1 Link2

Does cancer that occurs during or after anti-tumor necrosis factor therapy have a worse prognosis? A national assessment of overall and site-specific cancer survival in rheumatoid arthritis patients treated with biologic agents
Arthritis & Rheumatism. 2011;63(7):1812-1822   Crossref logo
Link1

Anti-tumor necrosis factor ? therapy and the risk of lymphoma in rheumatoid arthritis: No clear answer
Arthritis & Rheumatism. 2004;50(6):1703-1706   Crossref logo
Link1 Link2

PMS16 COST OF RHEUMATOID ARTHRITIS PATIENTS RECEIVING TNF-ANTAGONIST THERAPY FROM THE KOREA NATIONAL HEALTH INSURANCE CLAIMS DATABASE
Value in Health. 2011;14(3):A125-A126   Crossref logo
Link1 Link2

Prophylaxis for Latent Tuberculosis Infection Prior to Anti-Tumor Necrosis Factor Therapy in Low-Risk Elderly Patients With Rheumatoid Arthritis: A Decision Analysis
Arthritis Care & Research. 2013;65(11):1722-1731   Crossref logo
Link1

Lymphoma in rheumatoid arthritis: The effect of methotrexate and anti-tumor necrosis factor therapy in 18,572 patients
Arthritis & Rheumatism. 2004;50(6):1740-1751   Crossref logo
Link1 Link2

Risk of Mortality, Fatal Infection, and Fatal Malignancy Related to Use of Anti-Tumor Necrosis Factor-α Biologics by Rheumatoid Arthritis Patients
Seminars in Arthritis and Rheumatism. 2012;42(3):223-233   Crossref logo
Link1 Link2

Estimating The Prevalece of Depression In Patients With Rheumatoid Arthritis In Korea Using National Health Insurance Claims Data
Value in Health. 2017;20(9):A528   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Korean J Intern Med has participated in CrossRef Text and Data Mining service since August 31, 2015.